Obianda, Anna Mae T.

HRN: 20-40-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFUROXIME 750MG (VIAL)
05/24/2022
05/31/2022
IVT
750mg
Q8
For OR

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines